RIME

#4959
Algorhythm Holdings, Inc. - Common Stock
0.2 6 USD
-0.07%
Market Price
Sektor: Technologie
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.26
0.26
Jahresspanne
0.22
4.58
Tagesänderung
-7.14%
Monatliche Änderung
-36.59%
6 month change
-84.05%
Jahresänderung
-87.85%
Vorheriger Schlusskurs
0.2 8
Open
0.2 6
Tief
0.2 6
Hoch
0.2 6
Volumen
4
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Algorhythm Holdings, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Algorhythm Holdings, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Algorhythm Holdings, Inc. quarterly report, Q1 FY2026
10-Q

Algorhythm Holdings, Inc. current report, Q1 FY2025

Full document

Algorhythm Holdings, Inc. (RIME) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Algorhythm Holdings, Inc. on January 17, 2025, covering events occurring on January 13 and January 14, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "RIME".

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and capital structure changes.

Material Changes

  • Reverse Stock Split: On January 14, 2025, the Board of Directors determined to effect a reverse stock split of the Company's common stock at a ratio of 1-for-200. This action falls within the 1-for-10 to 1-for-250 range previously authorized by stockholders on January 13, 2025.
  • Authorized Share Increase: The Company amended its Certificate of Incorporation to increase the number of authorized common stock shares from 100,000,000 to 800,000,000.
  • Regulatory Filing: The Certificate of Amendment effecting the reverse split and share increase was filed with the Secretary of State of Delaware on January 14, 2025.
  • Market Status: As of the filing date, the reverse stock split has not yet taken effect in the public markets.

Guidance, Outlook, and Risks

The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the structural changes to the capitalization. The primary contingency noted is the pending effective date of the reverse stock split in public markets.

Key Facts for Investor Verification

  • Verify the exact effective date of the 1-for-200 reverse stock split on Nasdaq.
  • Confirm the updated share count and authorized share limit post-split.
  • Review the Certificate of Amendment (Exhibit 3.1) for specific terms regarding fractional shares or rounding procedures.
  • Monitor subsequent filings for the official implementation of the split in trading systems.